Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers' Diarrhea.-临床诊疗知识库

首页 > Emerging infectious diseases > Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and An...

收藏 | 浏览53

Antimicrobial drug treatment of travelers' diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers' diarrhea, the colonization rate without medications was 21

作者：Anu, Kantele；Sointu, Mero；Juha, Kirveskari；Tinja, L??veri

来源：Emerging infectious diseases 2016 年 22卷 1期

循证病因

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求，方便快速、便捷的获取实用的医学信息，辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍

热门关注

免责声明：本知识库提供的有关内容等信息仅供学习参考，不代替医生的诊断和医嘱。

Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers' Diarrhea.

| 浏览：53

作者：

Anu, Kantele；Sointu, Mero；Juha, Kirveskari；Tinja, L??veri

来源：

Emerging infectious diseases 2016 年 22卷 1期

标签：

AMD ESBL antibiotic resistance antibiotics antidiarrheal antimicrobial drugs antimicrobial resistance diarrhea extended-spectrum beta-lactamase–producing Enterobacteriaceae loperamide travel travel health travel medicine travelers’ diarrhea

知识库介绍

详细介绍

临床诊疗知识库现支持机构用户及个人包时用户开通服务。如需开通机构账号，请机构管理员联系我们，联系电话：010-58882667；个人包时开通请直接点击“个人包时订购”，开通后即可使用。